Use of Dexamethasone, Remdesivir Against COVID-19 Varied Widely Across U.S. Health Systems
As many as one-fifth of patients hospitalized with severe COVID-19 in the U.S. who may have benefitted from treatment with dexamethasone or closely related drugs were not given such treatment at the height of the pandemic.
